---
title: "Why XCF Global Shares Are Trading Higher By Around 65%; Here Are 20 Stocks Moving Premarket"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/302266353.md"
description: "XCF Global shares surged 64.9% premarket following a business combination and updated 2025 revenue/EBITDA forecasts. Other notable movers include iPower (+41.5%), Atlantic American (+41.9%), and Top Wealth Group (+34.3%). On the downside, Rubico fell 39.3% after announcing a convertible notes offering, while CL Workshop (-37%) and Sangrix (-30.8%) also declined significantly in early trading."
datetime: "2026-10-19T08:46:23.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/302266353.md)
  - [en](https://longbridge.com/en/news/302266353.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/302266353.md)
generator: "portal-rs"
---

# Why XCF Global Shares Are Trading Higher By Around 65%; Here Are 20 Stocks Moving Premarket

Shares of **XCF Global Inc** (NASDAQ:SAFX) rose sharply in pre-market trading.

XCF Global completed its business combination with Southern Energy Renewables and DevvStream and updated its 2027 financial outlook.

The company now sees 2025 net revenue of $120 to $130 million and EBITDA of $70 to $75 million.

XCF Global shares jumped 64.9% to $0.23 in pre-market trading

Here are some other stocks moving in pre-market trading.

### Gainers

-   **iPower Inc** (NASDAQ:IPW) gained 41.5% to $0.57 in pre-market trading. iPower, on Friday, registered up to 26.5 million shares underlying $3 million Series A convertible notes.
-   **Atlantic American Corp** (NASDAQ:AAME) gained 41.9% to $1.49 in pre-market trading.
-   **Top Wealth Group Holding Ltd** (NASDAQ:TWG) jumped 34.3% to $0.081 in pre-market trading after dipping 42% on Friday.
-   **Disc Medicine Inc** (NASDAQ:IRON) gained 26.7% to $72.00 in pre-market trading.
-   **Zone Frontier Inc** (NYSE:ZONE) rose 26.1% to $0.12 in pre-market trading after dipping 20% on Friday.
-   **Akari Therapeutics PLC** (NASDAQ:AKTX) gained 22.3% to $10.00 in pre-market trading after declining 6% on Friday. Akari Therapeutics, last week, highlighted progress toward AKTX-101 Phase 1 development and growing demand for its PH1 ADC payload platform.
-   **Actuate Therapeutics Inc** (NASDAQ:ACTU) gained 14.1% to $0.69 in pre-market trading after jumping 21% on Friday.
-   **Nextnav Inc** (NASDAQ:NN) gained 8.1% to $10.37 in pre-market trading after dipping 10% on Friday.
-   **Roze AI** (NASDAQ:RZAI) rose 7.4% to $10.55 in pre-market trading.  

### Losers

-   **Rubico Inc.** (NASDAQ:RUBI) fell 39.3% to $0.2375 in pre-market trading after the company announced an $8.5 million registered direct offering of senior convertible notes and warrants.
-   **CL Workshop Group Limited** (NASDAQ:NWGL) fell 37% to $0.1475 in pre-market trading after gaining around 6% on Friday.
-   **Sangrix Inc**. (NASDAQ:SGRX) fell 30.8% to $0.6001 in pre-market trading. Sangrix shares jumped around 27% on Friday after the company announced that its 16 NVIDIA Blackwell B300 AI servers, totaling 128 GPUs, are expected to be delivered in early November 2026.
-   **ATA Creativity Global** (NASDAQ:AACG) fell 22.5% to $0.74 in pre-market trading after climbing 53% on Friday.
-   **22nd Century Group, Inc.** (NASDAQ:XXII) fell 22.1% to $0.2611 in pre-market trading after dipping 47% on Friday. 22nd Century Group announced that combined same-store retail unit sales of Pinnacle VLN and Pinnacle Pure increased 161% from Q2 to Q3.
-   **Robin Energy Ltd**. (NASDAQ:RBNE) fell 20.5% to $0.6200 in pre-market trading after dipping 60% on Friday. Robin Energy filed prospectus for offering 3.093 million common shares.
-   **XCHG Limited** (NASDAQ:XCH) fell 17.5% to $2.15 in pre-market trading after gaining around 5% on Friday.
-   **House of Doge Inc**. (NASDAQ:HODO) tumbled 16.6% to $0.0775 in pre-market trading after jumping around 37% on Friday.
-   **Robo.ai Inc** (NASDAQ:AIIO) fell 15.5% to $0.73 in pre-market trading. Robo.ai announced a 1-for-25 reverse stock split, effective Nov. 6.
-   **VinFast Auto Ltd** (NASDAQ:VFS) declined 4.2% to $2.99 in pre-market trading after declining around 3% on Friday.

*Photo via Shutterstock*

### Related Stocks

- [46265P206.US](https://longbridge.com/en/quote/46265P206.US.md)
- [AACG.US](https://longbridge.com/en/quote/AACG.US.md)
- [AAME.US](https://longbridge.com/en/quote/AAME.US.md)
- [ACTU.US](https://longbridge.com/en/quote/ACTU.US.md)
- [AIIO.US](https://longbridge.com/en/quote/AIIO.US.md)
- [AKTX.US](https://longbridge.com/en/quote/AKTX.US.md)
- [BHAC.US](https://longbridge.com/en/quote/BHAC.US.md)
- [HODO.US](https://longbridge.com/en/quote/HODO.US.md)
- [IPW.US](https://longbridge.com/en/quote/IPW.US.md)
- [IRON.US](https://longbridge.com/en/quote/IRON.US.md)
- [NN.US](https://longbridge.com/en/quote/NN.US.md)
- [NWGL.US](https://longbridge.com/en/quote/NWGL.US.md)
- [NWTN.US](https://longbridge.com/en/quote/NWTN.US.md)
- [RBNE.US](https://longbridge.com/en/quote/RBNE.US.md)
- [RBNEV.US](https://longbridge.com/en/quote/RBNEV.US.md)
- [RUBI.US](https://longbridge.com/en/quote/RUBI.US.md)
- [SAFX.US](https://longbridge.com/en/quote/SAFX.US.md)
- [TWG.US](https://longbridge.com/en/quote/TWG.US.md)
- [XCH.US](https://longbridge.com/en/quote/XCH.US.md)
- [XXII.US](https://longbridge.com/en/quote/XXII.US.md)
- [ZONE.US](https://longbridge.com/en/quote/ZONE.US.md)
- [DEVSF.US](https://longbridge.com/en/quote/DEVSF.US.md)
- [NVDA.US](https://longbridge.com/en/quote/NVDA.US.md)
- [SGRX.US](https://longbridge.com/en/quote/SGRX.US.md)

## Related News & Research

- [XCHG Limited Announces Extraordinary Meeting and Share-Capital Proposals](https://longbridge.com/en/news/304150135.md)
- [Robo.ai Subsidiary Neurovia AI Highlights NeuroStream™ as an Enabler of Scalable, Sovereign Government AI Infrastructure | AIIO Stock News](https://longbridge.com/en/news/304101154.md)
- [Zone Frontier completes sale of legacy CleanCore cleaning products business](https://longbridge.com/en/news/303748547.md)
- [XCHG Announces Extraordinary General Meeting of Shareholders](https://longbridge.com/en/news/304147894.md)
- [Actuate Therapeutics Receives US Patent Allowance for Elraglusib Oral Tablets](https://longbridge.com/en/news/303960774.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**